FP7 project on toxicity of nanomaterials
Researchers from Sweden, Finland, Germany, United Kingdom, Switzerland and the United States have been awarded ¬ 3.358.500 from the European Commission to study the hazardous effects of engineered nanomaterials on the immune system. The project NANOMMUNE is coordinated by Bengt Fadeel, M.D, Ph.D., at the Institute of Environmental Medicine, and will continue for 3 years. The interdisciplinary network consists of experts in material sciences, cell biology, immunology, toxicology, systems biology and risk assessment.
Engineered nanomaterials (ENs, particles 100>
Through our comprehensive approach, which combines different disciplines, we aim to analyze and predict the toxic potential of existing and emerging ENs on key functions of the immune system. A detailed physico-chemical characterization of ENs is also an integrative part of the project. Overall, the NANOMMUNE project results will enhance the understanding of possible adverse effects of nanomaterials and will contribute to a continuous and sustainable growth of the nanotechnologies.
The NANOMMUNE project was launched on September 1st 2008 and will run for 3 years. The project is funded by the European Commission through the 7th Framework Programme by the funding scheme of Collaborative projects, in the area of Nanosciences, Nanotechnologies, Materials and New Production Technologies (NMP).